Jia-Wei Sun , Hsiang-Chih Hsu , Jie-Syuan Wu , Tsai-Wei Huang , Yuan-Si Tsai , Wun-Hao Cheng , Lee-Yuan Lin
{"title":"间质性肺疾病的睡眠呼吸暂停:患病率、严重程度和危险因素的系统回顾和荟萃分析","authors":"Jia-Wei Sun , Hsiang-Chih Hsu , Jie-Syuan Wu , Tsai-Wei Huang , Yuan-Si Tsai , Wun-Hao Cheng , Lee-Yuan Lin","doi":"10.1016/j.sleep.2025.106768","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Obstructive sleep apnea (OSA) is common in interstitial lung disease (ILD) patients and affects disease progression and outcomes. This meta-analysis aims to estimate OSA prevalence in ILD and examine associations with lung function parameters and risk factors.</div></div><div><h3>Methods</h3><div>PubMed, Embase, and Cochrane Library were searched for studies assessing OSA prevalence or apnea-hypopnea index (AHI) in ILD, published before February 2025. Primary outcomes were OSA prevalence and severity (assessed by AHI). Secondary outcomes assessed the influence of forced vital capacity (FVC), diffusing capacity of the lungs for carbon monoxide (DL<sub>CO</sub>), 6-min walk distance (6MWD), BMI, smoking rate, and male percentage. The study protocol was registered in PROSPERO (CRD420250650698).</div></div><div><h3>Results</h3><div>17 studies comprising 1092 participants were included. Meta-analysis revealed an OSA prevalence of 68 % (95 % CI: 59–75 %), with higher rates in IPF (71 %, 95 % CI: 61–80 %) than non-IPF ILD. The pooled mean AHI was 13.36 (95 % CI: 10.87–16.41); moderate-to-severe OSA prevalence was 36 %. In multivariate analysis, OSA prevalence was associated with lower FVC (<em>P</em> = 0.086), male sex (<em>P</em> < 0.05), and BMI (<em>P</em> = 0.065–0.081). AHI was mildly associated with 6MWD (<em>P</em> = 0.086) and BMI (<em>P</em> = 0.065–0.084). Subgroup analyses identified that ILD patients with FVC < 80 % (<em>P</em> = 0.065), 6MWD < 372 m (<em>P</em> = 0.036), and BMI > 31 kg/m<sup>2</sup> (<em>P</em> = 0.21) were at increased risk for OSA.</div></div><div><h3>Conclusion</h3><div>Given the high OSA prevalence in ILD patients, routine screening—particularly in males with FVC < 80 % predicted, BMI > 31 kg/m<sup>2</sup>, or 6MWD < 372 m—is recommended. Early detection may enable timely intervention and improve outcomes.</div></div>","PeriodicalId":21874,"journal":{"name":"Sleep medicine","volume":"136 ","pages":"Article 106768"},"PeriodicalIF":3.4000,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sleep apnea in interstitial lung disease: A systematic review and meta-analysis of prevalence, severity, and risk factors\",\"authors\":\"Jia-Wei Sun , Hsiang-Chih Hsu , Jie-Syuan Wu , Tsai-Wei Huang , Yuan-Si Tsai , Wun-Hao Cheng , Lee-Yuan Lin\",\"doi\":\"10.1016/j.sleep.2025.106768\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Obstructive sleep apnea (OSA) is common in interstitial lung disease (ILD) patients and affects disease progression and outcomes. This meta-analysis aims to estimate OSA prevalence in ILD and examine associations with lung function parameters and risk factors.</div></div><div><h3>Methods</h3><div>PubMed, Embase, and Cochrane Library were searched for studies assessing OSA prevalence or apnea-hypopnea index (AHI) in ILD, published before February 2025. Primary outcomes were OSA prevalence and severity (assessed by AHI). Secondary outcomes assessed the influence of forced vital capacity (FVC), diffusing capacity of the lungs for carbon monoxide (DL<sub>CO</sub>), 6-min walk distance (6MWD), BMI, smoking rate, and male percentage. The study protocol was registered in PROSPERO (CRD420250650698).</div></div><div><h3>Results</h3><div>17 studies comprising 1092 participants were included. Meta-analysis revealed an OSA prevalence of 68 % (95 % CI: 59–75 %), with higher rates in IPF (71 %, 95 % CI: 61–80 %) than non-IPF ILD. The pooled mean AHI was 13.36 (95 % CI: 10.87–16.41); moderate-to-severe OSA prevalence was 36 %. In multivariate analysis, OSA prevalence was associated with lower FVC (<em>P</em> = 0.086), male sex (<em>P</em> < 0.05), and BMI (<em>P</em> = 0.065–0.081). AHI was mildly associated with 6MWD (<em>P</em> = 0.086) and BMI (<em>P</em> = 0.065–0.084). Subgroup analyses identified that ILD patients with FVC < 80 % (<em>P</em> = 0.065), 6MWD < 372 m (<em>P</em> = 0.036), and BMI > 31 kg/m<sup>2</sup> (<em>P</em> = 0.21) were at increased risk for OSA.</div></div><div><h3>Conclusion</h3><div>Given the high OSA prevalence in ILD patients, routine screening—particularly in males with FVC < 80 % predicted, BMI > 31 kg/m<sup>2</sup>, or 6MWD < 372 m—is recommended. Early detection may enable timely intervention and improve outcomes.</div></div>\",\"PeriodicalId\":21874,\"journal\":{\"name\":\"Sleep medicine\",\"volume\":\"136 \",\"pages\":\"Article 106768\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-08-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sleep medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1389945725004435\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1389945725004435","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Sleep apnea in interstitial lung disease: A systematic review and meta-analysis of prevalence, severity, and risk factors
Background
Obstructive sleep apnea (OSA) is common in interstitial lung disease (ILD) patients and affects disease progression and outcomes. This meta-analysis aims to estimate OSA prevalence in ILD and examine associations with lung function parameters and risk factors.
Methods
PubMed, Embase, and Cochrane Library were searched for studies assessing OSA prevalence or apnea-hypopnea index (AHI) in ILD, published before February 2025. Primary outcomes were OSA prevalence and severity (assessed by AHI). Secondary outcomes assessed the influence of forced vital capacity (FVC), diffusing capacity of the lungs for carbon monoxide (DLCO), 6-min walk distance (6MWD), BMI, smoking rate, and male percentage. The study protocol was registered in PROSPERO (CRD420250650698).
Results
17 studies comprising 1092 participants were included. Meta-analysis revealed an OSA prevalence of 68 % (95 % CI: 59–75 %), with higher rates in IPF (71 %, 95 % CI: 61–80 %) than non-IPF ILD. The pooled mean AHI was 13.36 (95 % CI: 10.87–16.41); moderate-to-severe OSA prevalence was 36 %. In multivariate analysis, OSA prevalence was associated with lower FVC (P = 0.086), male sex (P < 0.05), and BMI (P = 0.065–0.081). AHI was mildly associated with 6MWD (P = 0.086) and BMI (P = 0.065–0.084). Subgroup analyses identified that ILD patients with FVC < 80 % (P = 0.065), 6MWD < 372 m (P = 0.036), and BMI > 31 kg/m2 (P = 0.21) were at increased risk for OSA.
Conclusion
Given the high OSA prevalence in ILD patients, routine screening—particularly in males with FVC < 80 % predicted, BMI > 31 kg/m2, or 6MWD < 372 m—is recommended. Early detection may enable timely intervention and improve outcomes.
期刊介绍:
Sleep Medicine aims to be a journal no one involved in clinical sleep medicine can do without.
A journal primarily focussing on the human aspects of sleep, integrating the various disciplines that are involved in sleep medicine: neurology, clinical neurophysiology, internal medicine (particularly pulmonology and cardiology), psychology, psychiatry, sleep technology, pediatrics, neurosurgery, otorhinolaryngology, and dentistry.
The journal publishes the following types of articles: Reviews (also intended as a way to bridge the gap between basic sleep research and clinical relevance); Original Research Articles; Full-length articles; Brief communications; Controversies; Case reports; Letters to the Editor; Journal search and commentaries; Book reviews; Meeting announcements; Listing of relevant organisations plus web sites.